6533b85ffe1ef96bd12c1aa1

RESEARCH PRODUCT

First-in-human study of IMAB362, an anti-claudin 18.2 monoclonal antibody, in patients with advanced gastroesophageal cancer

Ö. TüreciChristoph HuberM. UtschMartin SchulerA. KrilovaS. BauerUgur Sahin

subject

Gastroesophageal cancerOncologybusiness.industrymedicine.drug_classCancer researchMedicineIn patientHuman studyHematologyClaudinbusinessMonoclonal antibodyIMAB362https://doi.org/10.1093/annonc/mdx369.044